Search

Your search keyword '"Petrucci, Alessia"' showing total 13 results
Start Over Author "Petrucci, Alessia"
13 results on '"Petrucci, Alessia"'

1. Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 Trial

Author

Maddalo, Marta, Borghetti, Paolo, Tomasini, Davide, Corvò, Renzo, Bonomo, Pierluigi, Petrucci, Alessia, Paiar, Fabiola, Lastrucci, Luciana, Bonù, Marco Lorenzo, Greco, Diana, Costa, Loredana, Pegurri, Ludovica, Triggiani, Luca, Belgioia, Liliana, Desideri, Isacco, Grisanti, Salvatore, Buglione, Michela, and Magrini, Stefano Maria

Published
2020
Full Text
View/download PDF

4. Effect of Insulin Glargine on Cardiovascular Risk Analysed by Mean HRV

Author

Apicella Giovanni, Dal Maso Serenella Gioia, Marcinnò Mariaconcetta, Raimondi Gianfranco, Petrucci Alessia, and Marchitto Nicola

Subjects
cardiovascular risk, medicine.medical_specialty, diabetes, Heart disease, Diet therapy, Insulin glargine, business.industry, geriatry, Insulin, medicine.medical_treatment, HRV, Type 2 Diabetes Mellitus, insulin glargine, Disease, medicine.disease, Pharmacotherapy, Internal medicine, Diabetes mellitus, Cardiology, medicine, business, medicine.drug
Abstract

Type 2 diabetes mellitus is an insidious disease that is increasingly present in geriatric population [1]. The greatest difficulty is represented by glycaemic control in geriatric patients often not very compliant with diet therapy and drug therapy. A new insulin glargine 300 units/ml formulation seems improve patient compliance due to the lower volume of insulin to be injected and improved glycaemic control over 24 hours. The HRV signal, derived from digital electrocardiographic recording, is the simplest and most immediate analysis that consists in calculating some temporal parameters [2]. HRV is a simple statistics derived from beat-beat intervals of sinus origin expressed as units of time in milliseconds. Data in the literature indicate that a decrease in HRV, measured with time domain analysis, denotes a worse prognosis and/or an increased risk of mortality in patients with heart disease, especially in the elderly ones.

Published
2019

5. CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL

Author

Maddalo, Marta, Borghetti, Paolo, Tomasini, Davide, Corvò, Renzo, Bonomo, Pierluigi, Petrucci, Alessia, Paiar, Fabiola, Lastrucci, Luciana, Bonù, Marco Lorenzo, Greco, Diana, Costa, Loredana, Pegurri, Ludovica, Triggiani, Luca, Belgioia, Liliana, Desideri, Isacco, Grisanti, Salvatore, Buglione, Michela, and Magrini, Stefano Maria

Published
2020

7. Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial

Author

Magrini, Stefano Maria, primary, Buglione, Michela, additional, Corvò, Renzo, additional, Pirtoli, Luigi, additional, Paiar, Fabiola, additional, Ponticelli, Pietro, additional, Petrucci, Alessia, additional, Bacigalupo, Almalina, additional, Crociani, Monica, additional, Lastrucci, Luciana, additional, Vecchio, Stefania, additional, Bonomo, Pierluigi, additional, Pasinetti, Nadia, additional, Triggiani, Luca, additional, Cavagnini, Roberta, additional, Costa, Loredana, additional, Tonoli, Sandro, additional, Maddalo, Marta, additional, and Grisanti, Salvatore, additional

Published
2016
Full Text
View/download PDF

10. Non-Pegylated Liposomal Doxorubicin in Combination with Cyclophosphamide or Docetaxel as First-Line Therapy in Metastatic Breast Cancer: A Retrospective Analysis

Author

Livi, Lorenzo, primary, Meattini, Icro, additional, De Luca Cardillo, Carla, additional, Mangoni, Monica, additional, Greto, Daniela, additional, Petrucci, Alessia, additional, Rampini, Andrea, additional, Bruni, Alessio, additional, Galardi, Alessandra, additional, Cataliotti, Luigi, additional, and Biti, Giampaolo, additional

Published
2009
Full Text
View/download PDF

11. Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience

Author

Livi, Lorenzo, primary, Borghesi, Simona, additional, Saieva, Calogero, additional, Meattini, Icro, additional, Rampini, Andrea, additional, Petrucci, Alessia, additional, Detti, Beatrice, additional, Bruni, Alessio, additional, Paiar, Fabiola, additional, Mangoni, Monica, additional, Marrazzo, Livia, additional, Agresti, Benedetta, additional, Cataliotti, Luigi, additional, Bianchi, Simonetta, additional, and Biti, Giampaolo, additional

Published
2009
Full Text
View/download PDF

12. Concurrent Cyclophosphamide, Methotrexate, and 5-Fluorouracil Chemotherapy and Radiotherapy for Early Breast Carcinoma

Author

Livi, Lorenzo, primary, Saieva, Calogero, additional, Borghesi, Simona, additional, Paoletti, Lisa, additional, Meattini, Icro, additional, Rampini, Andrea, additional, Petrucci, Alessia, additional, Scoccianti, Silvia, additional, Paiar, Fabiola, additional, Cataliotti, Luigi, additional, Leonulli, Barbara Grilli, additional, Bianchi, Simonetta, additional, and Biti, Gian Paolo, additional

Published
2008
Full Text
View/download PDF

13. Postoperative Radiotherapy in Stage I/II Endometrial Cancer.

Author

Scotti, Vieri, Borghesi, Simona, Meattini, Icro, Saieva, Calogero, Rossi, Francesca, Petrucci, Alessia, Galardi, Alessandra, Livi, Lorenzo, Agresti, Benedetta, Fambrini, Massimiliano, Marchionni, Mauro, and Biti, Giampaolo

Abstract

The efficacy of postoperative radiotherapy (RT) in the treatment of early-stage endometrial carcinoma (EC) is still under debate. This study was aimed to review the outcome and adverse effects in patients treated for EC with postoperative RT at a single center.A total of 883 patients with pathological stages I to II EC were retrospectively analyzed. Surgery consisted of total abdominal hysterectomy and bilateral salpingo-oophorectomy, or vaginal hysteroannessiectomy in 532 patients (60.2%) with pelvic lymphadenectomy in 351 patients (39.8%). Seven hundred forty-seven patients (84.6%) underwent whole pelvic RT (WPRT) and 136 (15.4%) combined WPRT and vaginal brachytherapy (BT) boost.At a median follow-up of 9 years (range, 1.2-27.6 years), we observed 10.6% disease relapse. Forty-seven patients experienced local recurrence (LR), and 38 patients experienced distant metastases (DMs). At univariate analysis, age at diagnosis (P < 0.0001), stage (P < 0.04), and histological subtype (P < 0.0001) resulted in significant prognostic factors. At multivariate analysis, histotype emerged as an independent relapse predictor (P = 0.0001). Acute WPRT-related toxicity was mild; diarrhea was the most common adverse effect (19.8%). We recorded long-term adverse effects in 7.8% of the patients.Our study showed that patients with early-stage EC have a good outcome in overall survival and disease-free survival. In our experience, standard surgery (including hysterectomy and bilateral salpingo-oophorectomy followed by WPRT with or without BT) showed an acceptable toxicity profile. [ABSTRACT FROM AUTHOR]

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results